Y 27152

Drug Profile

Y 27152

Latest Information Update: 13 May 1998

Price : $50

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Developer Japan Tobacco; Mitsubishi Pharma Corporation
  • Class
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Angina pectoris; Hypertension

Most Recent Events

  • 13 May 1998 Discontinued-II for Angina pectoris in Japan (PO)
  • 13 May 1998 Discontinued-II for Hypertension in Japan (PO)
  • 26 Aug 1997 Phase-II clinical trials for Angina pectoris in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top